FR2589732B1 - NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL - Google Patents

NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL

Info

Publication number
FR2589732B1
FR2589732B1 FR868613668A FR8613668A FR2589732B1 FR 2589732 B1 FR2589732 B1 FR 2589732B1 FR 868613668 A FR868613668 A FR 868613668A FR 8613668 A FR8613668 A FR 8613668A FR 2589732 B1 FR2589732 B1 FR 2589732B1
Authority
FR
France
Prior art keywords
pindolol
release formulation
extended release
formulation based
new extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR868613668A
Other languages
French (fr)
Other versions
FR2589732A1 (en
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2589732A1 publication Critical patent/FR2589732A1/en
Application granted granted Critical
Publication of FR2589732B1 publication Critical patent/FR2589732B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR868613668A 1985-10-01 1986-10-01 NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL Expired FR2589732B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2589732A1 FR2589732A1 (en) 1987-05-15
FR2589732B1 true FR2589732B1 (en) 1989-07-13

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868613668A Expired FR2589732B1 (en) 1985-10-01 1986-10-01 NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
EP1383496B1 (en) * 2001-02-20 2008-10-01 Dinan, Timothy Gerard Treatment of fibromyalgia using pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (en) * 1984-03-21 1985-12-26 죠지 드모트 Sustained Release Pharmaceutical Wexel
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
SE8604112L (en) 1987-04-02
HU197201B (en) 1989-03-28
ATA260486A (en) 1996-08-15
PT83456B (en) 1989-05-12
HUT44701A (en) 1988-04-28
IL80182A0 (en) 1986-12-31
DE3632201C2 (en) 1997-05-07
KR870003777A (en) 1987-05-04
GR862457B (en) 1987-01-29
BE905516A (en) 1987-03-30
PT83456A (en) 1986-10-01
NZ217732A (en) 1990-07-26
NL194822B (en) 2002-12-02
DK464686D0 (en) 1986-09-29
CH669524A5 (en) 1989-03-31
KR920008817B1 (en) 1992-10-09
CA1298784C (en) 1992-04-14
AT402257B (en) 1997-03-25
SE503222C2 (en) 1996-04-22
DE3632201A1 (en) 1987-04-02
IE59589B1 (en) 1994-03-09
IL80182A (en) 1991-01-31
DK464686A (en) 1987-04-02
NL194822C (en) 2003-04-03
FR2589732A1 (en) 1987-05-15
ES2002508A6 (en) 1988-08-16
DK170016B1 (en) 1995-05-01
SG103391G (en) 1992-01-17
SE8604112D0 (en) 1986-09-29
IE862565L (en) 1987-04-01
HK392A (en) 1992-01-10
LU86615A1 (en) 1987-04-02
NL8602370A (en) 1987-05-04

Similar Documents

Publication Publication Date Title
IT8648451A0 (en) ANTI-TARTAR ORAL COMPOSITION
BE865150A (en) ANCHOR BASE
BR8907584A (en) FLUORPOLIMER BASED COATING COMPOSITION
IT8620877A0 (en) PETROL-BASED COMPOSITION.
FR2634377B1 (en) NOVEL EXTENDED RELEASE PHARMACEUTICAL FORM BASED ON AN ACTIVE RESIN-PRINCIPLE COMPLEX
IT8521654A0 (en) SLOW RELEASE TOPICAL FORMULATIONS.
FR2580495B1 (en) EMULSANNE-BASED DENTAL PREPARATION
ES2025120B3 (en) DEVICE FOR DECORATING OBJECTS
KR870700539A (en) anchor
DK165034C (en) MARKING DEVICES
ATA225988A (en) SELF-FAIRING STAMP
FR2589732B1 (en) NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL
PT91948A (en) PROCESS FOR THE PREPARATION OF COMPOSITIONS BASED ON IGNIFIABLE POLYAMIDES
KR890015333A (en) Carla Awards
FR2638755B1 (en) CURABLE SILICONE COMPOSITIONS
PT92682A (en) PROCESS FOR THE PREPARATION OF A COMPOSITION BASED ON PRIME-RELEASED LIBERALIZATION TRIMEBUTIN
IT1213320B (en) ORAL PHARMACEUTICAL COMPOSITION BASED ON UBICHINONI.
FR2521997B1 (en) NEW DRUG ASSOCIATION BASED ON MORNIFLUMATE
FR2583042B1 (en) ANALGESIC COMPOSITIONS BASED ON (ALKOXY-ALKYL-HYDROXY-PHENYL) CYCLOHEXANOL
IT7805210A0 (en) MULTI-SPOKE SUPPORT BASE FOR ARMCHAIRS
KR860012715U (en) Attached fragrance base
KR880004605U (en) Soap with base
ES552148A0 (en) PROCEDURE FOR PREPARING ANILAZIN-BASED FUNGICIDE COMPOSITIONS
MX163870B (en) BIOCIDAL COMPOSITION BASED ON ISOTIAZOLONE
ES1004832Y (en) EXTENSIBLE BASE FOR PARASOLES

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0174, 920507

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0167, 861001

CL Concession to grant licences
TP Transmission of property